Promotions & Moves

Boehringer Ingelheim Appoints New U.S. CEO

Jean-Michel Boers to succeed Dr. Wolfgang Baiker, who is retiring after 31 years.

By: Contract Pharma

Contract Pharma Staff

Dr. Wolfgang Baiker, U.S. Country Managing Director, President and CEO of Boehringer Ingelheim, will retire after 31 years on July 31, 2020. Jean-Michel Boers has been appointed to succeed him. Mr. Boers, currently President of Boehringer Ingelheim Pharmaceuticals, Inc., is responsible for the U.S. commercial and medical organization, and development of the company’s current primary and specialty care portfolio. He joined the company in 1998 in Belgium, and advanced through various rol...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters